The Investor With Joel Palathinkal
The Investor with Joel Palathinkal is a global omni channel show which highlights institutional investors from all walks of life and supports the continuing education for the next generation of allocators
Mary Wheeler: BioRock Ventures
Joel Palathinkal engages with Mary Wheeler, exploring her career journey and the founding of BioRock Ventures. They discuss investing in serious diseases and the significance of in-person interactions in the business realm. Mary shares insights into the investment criteria and evaluation of drug efficacy in the biopharma sector. The conversation highlights identifying successful biopharma founders and startups, along with the impact of simulation and modeling on innovation. They delve into the relevance of a PhD in venture capital and offer traits and advice for biopharma founders and venture managers. The episode concludes with effective fundraising strategies and closing thoughts.
Key Points
- Investing in biopharma requires a clear understanding of the product, patient group, and a well-defined plan to demonstrate efficacy and safety.
- The success of early-stage biopharma startups often hinges on experienced leadership familiar with the specific stages of drug development.
- When starting a venture capital fund, especially in the current challenging fundraising environment, it's crucial to adopt a scrappy entrepreneurial mindset, close deals quickly, and understand that securing investments is a numbers game.
Chapters
| 0:00 | |
| 2:02 | |
| 8:42 | |
| 12:07 | |
| 20:01 | |
| 25:01 | |
| 27:38 | |
| 34:51 | |
| 39:20 |
Transcript
Loading transcript...
- / -